Agenus Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.06

-0.09 (-2.86%)

As of Jun 30, 10:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,146.1% upside

Low Target $23.34

Average Target $38.13

High Target $40.06

Current Price $3.06

Current
$3.06

Target
$38.13

$23.34 $38.13 avg $40.06

Scenario Analysis

Bear Case

$23.34

662.7%

Low target

Base Case

$38.13

+1,146.1%

Avg target

Bull Case

$40.06

+1,209.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$7.34

-58.3% from high

52-Week Low

$2.71

+12.9% from low

Target vs 52W High

$38.13

+419.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%